All Academic, Inc. Research Logo

Info/CitationFAQResearchAll Academic Inc.

‘This Shot Can Save Your Life!’ (Or Can It?): Framing of the HPV Vaccine in Teen, Parenting, and Women’s Magazines
Unformatted Document Text:  ‘This Shot Can Save Your Life!’ (Or Can It?): Framing of the HPV Vaccine in Teen, Parenting, and Women’s Magazines ‘This Shot Can Save Your Life!’ (Or Can It?): Framing of the HPV Vaccine in Teen, Parenting, and Women’s Magazines Approximately 20 million people currently are infected with genital human papillomavirus (HPV), making it the most common sexually transmitted disease in the United States. 1 An additional 6.2 million people become newly infected each year. 2 The virus has more than 30 strains that can be transmitted through sexual contact, and about 50 percent of sexually active men and women become infected with HPV at some point in their lives. 3 Several of these strains are designated as high risk (types 16, 18, and many others) because they have been found to cause cervical cancer. 4 Other strains, such as types 6 and 11, are associated with genital warts. Cervical cancer is a particularly slow growing cancer, but estimates show that approximately 1.4 million women worldwide have cervical cancer, and approximately 7 million more have unidentified and untreated precancerous lesions. 5 Cervical cancer is the leading cause of cancer deaths among women in developing countries, and both in the United States and in the rest of the world, cervical cancer disproportionally affects poor and vulnerable women who have little access to regular health screenings and Pap tests. 6 In 2006, a highly effective vaccine (Gardasil) was approved that would protect against four strains of the virus (types 6, 11, 16, and 18) and recommended for use primarily among 11- and 12-year-old girls, and among girls and women ages nine to 26. 7 The CDC’s Advisory Committee on Immunization Practices recommended targeting adolescent girls because clinical research has shown that this is the optimum time for vaccination, as it is prior to sexual debut and there is a stronger immune response among adolescents. 8 This vaccine, manufactured in the

Authors: Lepre, Carolyn.
first   previous   Page 4 of 44   next   last

background image
‘This Shot Can Save Your Life!’ (Or Can It?): Framing of the HPV Vaccine in Teen, Parenting, 
and Women’s Magazines
‘This Shot Can Save Your Life!’ (Or Can It?): Framing of the HPV Vaccine in Teen, Parenting, 
and Women’s Magazines 
Approximately 20 million people currently are infected with genital human 
papillomavirus (HPV), making it the most common sexually transmitted disease in the United 
 An additional 6.2 million people become newly infected each year.
 The virus has more 
than 30 strains that can be transmitted through sexual contact, and about 50 percent of sexually 
active men and women become infected with HPV at some point in their lives.
 Several of these 
strains are designated as high risk (types 16, 18, and many others) because they have been found 
to cause cervical cancer.
 Other strains, such as types 6 and 11, are associated with genital warts. 
Cervical cancer is a particularly slow growing cancer, but estimates show that 
approximately 1.4 million women worldwide have cervical cancer, and approximately 7 million 
more have unidentified and untreated precancerous lesions.
 Cervical cancer is the leading cause 
of cancer deaths among women in developing countries, and both in the United States and in the 
rest of the world, cervical cancer disproportionally affects poor and vulnerable women who have 
little access to regular health screenings and Pap tests.
In 2006, a highly effective vaccine (Gardasil) was approved that would protect against 
four strains of the virus (types 6, 11, 16, and 18) and recommended for use primarily among 11- 
and 12-year-old girls, and among girls and women ages nine to 26.
 The CDC’s Advisory 
Committee on Immunization Practices recommended targeting adolescent girls because clinical 
research has shown that this is the optimum time for vaccination, as it is prior to sexual debut 
and there is a stronger immune response among adolescents.
 This vaccine, manufactured in the 

All Academic Convention can solve the abstract management needs for any association's annual meeting.
Submission - Custom fields, multiple submission types, tracks, audio visual, multiple upload formats, automatic conversion to pdf.
Review - Peer Review, Bulk reviewer assignment, bulk emails, ranking, z-score statistics, and multiple worksheets!
Reports - Many standard and custom reports generated while you wait. Print programs with participant indexes, event grids, and more!
Scheduling - Flexible and convenient grid scheduling within rooms and buildings. Conflict checking and advanced filtering.
Communication - Bulk email tools to help your administrators send reminders and responses. Use form letters, a message center, and much more!
Management - Search tools, duplicate people management, editing tools, submission transfers, many tools to manage a variety of conference management headaches!
Click here for more information.

first   previous   Page 4 of 44   next   last

©2012 All Academic, Inc.